Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: Results in 20 patients and review of the literature

British Journal of Haematology

Volumn 127, Issue 4, 2004, Pages 399-403

  Cervantes, Francisco ^a,d   Alvarez Larrá, Alberto ^a   Hernández Boluda, Juan Carlos ^b   Sureda, Ana ^c   Torrebadell, Montserrat ^a   Montserrat, Emili ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Anaemia; Erythropoietin; Idiopathic myelofibrosis; Myelofibrosis with myeloid metaplasia; Treatment

Indexed keywords

ANAGRELIDE; DANAZOL; ERYTHROPOIETIN; HEMOGLOBIN; HYDROXYUREA; IRON; PREDNISONE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; MALE; MULTIVARIATE ANALYSIS; MYELOFIBROSIS; MYELOID METAPLASIA; PRIORITY JOURNAL; REVIEW; SPLENOMEGALY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANEMIA; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOFIBROSIS; MYELOID METAPLASIA;

EID: 8844269106     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05229.x     Document Type: Review

References (24)

1. Aloe-Spiriti, M.A., Latagliata, R., Awisati, G., Battistel, V., Montefusco, E., Spadea, A. & Petti, M.C. (1993) Erythropoietin treatment of idiopathic myelofibrosis. Haetnatologica, 78, 371-373.
2. Barosi, G., Liberato, L.N. & Guarnone, R. (1993) Serum erythropoietin in patients with myelofibrosis with myeloid metaplasia. British Journal of Haematology, 83, 365-369.
3. Barosi, G., Ambrosetti, A., Finelli, G., Grossi, A., Leoni, P., Liberato, N.L., Petti, M.C., Pogliani, E., Ricetti, M., Rupoli, S., Visani, G. & Tura, S. (1999) The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia. British Journal of Haematology, 104, 730-737.
4. Bourantas, K.L., Tsiara, S., Christou, L., Repousis, P., Konstantinidou, P., Bai, M. & Seferiadis, K. (1996) Combination therapy with recombinant human erythropoietin, interferon-α-2b and granulocyte-macrophage colony-stimulating factor in idiopathic myelofibrosis. Acta Haematologica, 96, 79-82.
5. Cazzola, M., Ponchio, L., Beguin, Y., Rosti, V., Bergamaschi, G., Liberato, N.L., Fregoni, V., Nalli, G., Barosi, G. & Ascari, E. (1992) Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood, 79, 29-37.
6. Centenara, E., Guarnone, R., Ippoliti, G. & Barosi, G. (1998) Cyclosporin-A in severe refractory anemia of myelofibrosis with myeloid metaplasia: a preliminary report. Haematologica, 83, 622-626.
7. Cervantes, F., Pereira, A., Esteve, J., Rafel, M., Cobo, F., Rozman, C. & Montserrat, E. (1997) Identification of "long-lived" and "short-lived" patients at presentation of primary myelofibrosis. British Journal of Haematology, 97, 635-640.
8. Cervantes, F., Hernández-Boluda, J.C., Alvarez, A., Nadal, E. & Montserrat, E. (2000) Danazol treatment of idiopathic myelofibrosis with severe anemia. Haematologica, 85, 595-599.
9. Coleman, T.A., Hamill, R.L. & Ford, S.M. (2001) Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia. American Journal of Hematology, 67, 214-215.
10. Dupriez, B., Morel, P., Demory, J.L., Lai, J.L., Simon, M., Plantier, I. & Bauters, F. (1996) Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood, 88, 1013-1018.
11. Hasselbalch, H.C., Clausen, N.T. & Jensen, B.A. (2002) Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin. American Journal of Hematology, 70, 92-99.
12. Hast, R., Engstedt, L., Jameson, S., Killander, A., Lundh, B., Reizenstein, P., Skarberg, K.O., Uden, A.M. & Wadman, B. (1978) Oxymetholone treatment in myelofibrosis. Blut, 37, 19-26.
13. Hellström-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I.M., Dybedal, L, Grimfors, G., Kanter-Lewensohn, L., Linder, O., Luthman, M., Lofvenberg, E., Nilssson-Ehle, H., Samuelsson, J., Tangen, J., Winquist, I., Oberg, G., Osterborg, A. & Ost, A. (1998) Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomised phase II study and long-term follow-up of 71 patients. Blood, 92, 68-75.
14. Iki, S., Yasigawa, M., Ohbayasi, Y., Sato, H. & Urabe, A. (1991) Adverse effect of erythropoietin in myeloproliferative disorders. Lancet, 337, 187-188 (letter).
15. Jacobson, R.J., Salo, A. & Fialkow, P.J. (1978) Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood, 51, 189-194.
16. Kasper, C., Terhaar, A., Fossa, A., Welt, A., Seeber, S. & Nowrousian, M.R. (1997) Recombinant human erythropoietin in the treatment of cancer related anaemia. European Journal of Haematology, 58, 251-256.
17. Lennert, K., Naghai, K. & Schwarze, E.W. (1975) Patho-anatomical features of the bone marrow. Clinics in Haematology, 43, 331-351.
18. Mesa, R.A. & Tefferi, A. (2001) Palliative splenectomy in myelofibrosis with myeloid metaplasia. Leukemia and Lymphoma, 42, 901-911.
19. Mesa, R.A., Steensma, O.P., Pardanani, A., Li, C.Y., Elliott, M., Kaufmann, S.H., Wiseman, G., Gray, L.A., Schroeder, G., Reeder, T., Zeldis, J.B. & Tefferi, A. (2003) A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia. Blood, 101, 2534-2541.
20. Mittelman, M., Flora, S. & Djaldetti, M. (1992) Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Blood, 80, 841-842 (letter).
21. Mohr, B., Herrmann, R. & Huhn, D. (1993) Recombinant human erythropoietin in patients with myelodysplastic syndrome and myelofibrosis. Acta Haematologica, 90, 65-70.
22. Reilly, J.T. (1997) Idiopathic myelofibrosis: pathogenesis, natural history, and management. Blood Reviews, 11, 233-242.
23. Rodríguez, J.N., Martino, M.L., Diéguez, J.C. & Prados, D. (1998) RHuEPO for the treatment of anemia in myelofibrosis with myeloid metaplasia. Experience in 6 patients and meta-analytical approach. Haematologica, 83, 616-621.
24. Tefferi, A. & Silverstein, M.N. (1994) Recombinant human erythropoietin therapy in patients with myelofibrosis with myeloid metaplasia. British Journal of Haematology, 86, 893-896 (letter).